Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
The Exchange has sought clarification from Lasa Supergenerics Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Li...more...
The company reported standalone net loss during the quarter stood at Rs 2.55 crore compared to net profit of Rs 5.49 crore in the previous y...more...
Integrated filingmore...
Integated filingmore...
Integrated filing for quarter ended December 31 2025more...
Lasa Supergenerics Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
Results for quarter ended 31st December 2025more...
Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on February 13 2026.more...
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board...more...
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to co...more...
Structure Digital Databasemore...
As of December 2025 53.65% is owned by Indian Promoters and 46.35% by Public. Top Promoter holding highest number of shares of Lasa Supergen...more...
Lasa Supergenerics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018more...
Lasa Supergenerics Limited has informed the Exchange regarding Board meeting held on January 02 2026.more...
Pursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Boa...more...
Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio...more...
We wish to inform you that Mrs. Mitti Jain is hereby appoitned as Company secretary and Compliance Officer of the Companymore...
Lasa Supergenerics Limited has informed the Exchange regarding Cessation of MR. PRATHMESH CHALKE as Executive Director of the company w.e.f. December...more...
We would llike to inform you that Mr. Prathmesh Chalke tendered his resignation as Whole-time Director of the Company .more...
BOARD MEETINGS Company Name : Beryl Drugs Date : 01-04-2026